Comparing Autonomix Medical (AMIX) and The Competition

Autonomix Medical (NASDAQ:AMIX) is one of 236 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its competitors? We will compare Autonomix Medical to similar companies based on the strength of its profitability, risk, earnings, dividends, analyst recommendations, valuation and institutional ownership.

Profitability

This table compares Autonomix Medical and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-542.11%	-236.92%
Autonomix Medical Competitors	-574.62%	-156.70%	-27.31%

Earnings and Valuation

This table compares Autonomix Medical and its competitors gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Autonomix Medical	N/A	-$15.43 million	-0.34
Autonomix Medical Competitors	$1.02 billion	$10.48 million	-6.94

Autonomix Medical’s competitors have higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Institutional and Insider Ownership

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 47.9% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 32.4% of Autonomix Medical shares are owned by insiders. Comparatively, 15.6% of shares of all “Surgical & medical instruments” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Autonomix Medical and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	0	0	1	0	3.00
Autonomix Medical Competitors	1915	4912	9152	268	2.48

Autonomix Medical presently has a consensus price target of $28.00, suggesting a potential upside of 410.02%. As a group, “Surgical & medical instruments” companies have a potential upside of 15.30%. Given Autonomix Medical’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Autonomix Medical is more favorable than its competitors.

Autonomix Medical Company Profile

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.